{"id":"91269481588-28","name":"Novartis International AG","registrationDate":"2009-04-27T12:01:53.928+02:00","category":2,"subCategory":3,"legal":"Corporation","web":"http://www.novartis.com","country":"Switzerland","headAddress":"Novartis International AG","headCity":"Basel","headPostCode":"CH-4002","headPhone":"(41)6 13 24 11 11","boss":"Narasimhan Vas","bossTitle":"Mr","bossPosition":"Chief Executive Officer","membersCount":15,"membersFTE":"5.75","membership":"Among others, Novartis is a member of the following associations: BusinessEurope, British Chamber of Commerce, EFPIA, EuropaBio, Medicines for Europe, MedTech Europe","memberOrga":"","goal":"Our vision is to be a trusted leader in changing the practice of medicine. Our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.","acronym":"","interests":"Borders and Security, Business and Industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Employment and Social Affairs, Environment, External Relations, Institutional affairs, International co-operation and development, Justice and Fundamental Rights, Public Health, Regional Policy, Research and innovation, Single market, Taxation, Trade","euInitiatives":"Antimicrobial resistance (AMR)&#xd;<br />ATMP Regulation&#xd;<br />Big data&#xd;<br />Biosimilars &amp; generics&#xd;<br />Clinical Trials Regulation&#xd;<br />Data Protection Regulation&#xd;<br />EU IP policy&#xd;<br />EU Relative Efficacy Assessment (EU REA)&#xd;<br />EU research policy &#xd;<br />EU trade policy&#xd;<br />Health Systems Performance Assessment&#xd;<br />Health Technology Assessment &amp; Market Access&#xd;<br />Industrial policy&#xd;<br />Innovative Medicines Initiative (IMI) &#xd;<br />In-Vitro Diagnostic Regulation &#xd;<br />Medical Devices Regulation &#xd;<br />Outcomes-based healthcare systems&#xd;<br />Orphan Medicinal Products Regulation &#xd;<br />Paediatric Regulation&#xd;<br />Patient access to innovation&#xd;<br />Patient safety&#xd;<br />Pharmaceuticals in the environment&#xd;<br />Sustainable Development Goals","lastUp":"2019-10-23T16:13:49.119+02:00","customers":"","costAbsolu":"","costRange":"2250000-2499999","turnoverAbsolu":0,"turnoverRange":""}